COLUCCI, ROCCHINA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.191
EU - Europa 1.051
AS - Asia 925
SA - Sud America 66
AF - Africa 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.171
IT - Italia 417
CN - Cina 401
SG - Singapore 275
FI - Finlandia 224
VN - Vietnam 157
GB - Regno Unito 125
FR - Francia 83
CL - Cile 64
DE - Germania 64
IE - Irlanda 43
SE - Svezia 43
IN - India 17
CA - Canada 15
TR - Turchia 13
TW - Taiwan 10
ID - Indonesia 9
RO - Romania 8
JP - Giappone 7
NL - Olanda 7
PH - Filippine 7
UA - Ucraina 7
HK - Hong Kong 6
HR - Croazia 5
MX - Messico 5
PT - Portogallo 5
RU - Federazione Russa 5
EG - Egitto 4
ES - Italia 4
TH - Thailandia 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
LB - Libano 3
PK - Pakistan 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
KR - Corea 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BR - Brasile 1
CO - Colombia 1
EU - Europa 1
IQ - Iraq 1
KE - Kenya 1
MK - Macedonia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.246
Salva come PNG Salva come JPEG
Città #
Fairfield 1.976
Woodbridge 1.272
Houston 979
Ann Arbor 970
Ashburn 831
Seattle 708
Cambridge 657
Wilmington 609
Chandler 286
Boardman 254
San Diego 203
Medford 189
Princeton 189
Singapore 186
Des Moines 153
Dong Ket 152
Padova 144
Beijing 99
Helsinki 89
Nanjing 64
Roxbury 56
Verona 50
Dublin 42
Santa Clara 33
Shenyang 33
London 32
Santiago 32
New York 31
Hebei 28
Jinan 19
Quilpué 19
Guangzhou 16
Nanchang 16
Jiaxing 14
Pescara 14
Kilburn 11
Borås 10
Ningbo 10
Phoenix 10
Milan 9
Changsha 8
Chicago 8
Lappeenranta 8
Tianjin 8
Falls Church 7
Pune 7
Serra 7
Treviso 7
Viña del Mar 7
Indiana 6
Kharkiv 6
Norwalk 6
Redwood City 6
Tappahannock 6
Buttapietra 5
Campodarsego 5
Hounslow 5
Mestre 5
San Giórgio Di Nogaro 5
Vercelli 5
Zagreb 5
Berceni 4
Chorley 4
Columbus 4
East Hampton 4
Forest City 4
Frankfurt am Main 4
Hanoi 4
Kayseri 4
Montreal 4
New Bedfont 4
New Taipei 4
Piemonte 4
Shanghai 4
Taichung 4
Taizhou 4
Thiene 4
Turin 4
Villa Alemana 4
Zhengzhou 4
Baguio City 3
Beirut 3
Bengaluru 3
Bologna 3
Bolzano 3
Camerino 3
Chiswick 3
Groningen 3
Hamburg 3
Hangzhou 3
Islington 3
Istanbul 3
Lecce 3
Lissone 3
Manila 3
Marano sul Panaro 3
Nerviano 3
Novi Sad 3
Pisa 3
Pleven 3
Totale 10.763
Salva come PNG Salva come JPEG
Nome #
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 161
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 154
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 150
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 132
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 122
Tu1889 Targeting of NLRP3 Inflammasome With a Novel Selective Inhibitor as a Suitable Strategy for the Pharmacological Treatment of Bowel Inflammation 114
1077 AMP-Activated Protein Kinase as a Novel Target for the Pharmacological Treatment of Inflammatory Bowel Diseases 113
Impact of Antibiotic-Induced Microbiota Depletion on Small Bowel Excitatory and Inhibitory Neuromuscular Pathways in Adolescent Mice 113
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study 112
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 109
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 108
398 Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats 107
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 107
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 104
Mo2044 Irritable Bowel Syndrome, Serotonin Transporter 5HTTLPR Polymorphism and Psychopathological Traits: Dangerous Relations? 103
Anti-inflammatory effect of a novel locally acting A2Areceptor agonist in a rat model of oxazolone-induced colitis 103
L-histidine decarboxylase decreases its own transcription through downregulation of ERK activity 100
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 99
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 99
Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats. 98
Goodman & Gilman. Le basi farmacologiche della terapia. Con espansione online 98
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 97
Colonic Dysmotility Associated with High Fat Diet-Induced Obesity: Role of the Enteric Glia 97
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 97
H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways 96
Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized rats 96
Effects of L-DOPA/Benserazide Co-Treatment on the Patterns of Colonic Neuromuscular Excitatory Cholinergic and Tachykininergic Pathways in the Presence of Experimental Parkinson's Disease 96
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 96
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis 96
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 95
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 95
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 94
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 94
Histamine H3 receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves 93
SU2045 Characterization of Excitatory and Inhibitory Neuromuscolar Pathways Regulating Colonic Motility in a Rat Model of Parkinson's Disease 93
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 93
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 93
Su2089 Fibrotic Remodelling and Damage of the Colonic Neuromuscular Compartment in the Presence of Bowel Inflammation 90
Mo1810 Cyclooxygenase Inhibitors Counteract PRO-Fibrotic Signalling in Experimental Colitis Through Modulation of TGF-Beta/SMAD Network 90
Effects of maternal obesity and direct exposure to high-fat diet on bowel functions in offsprings 90
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 89
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 89
Colonic Dysmotility Associated With High Fat Diet-Induced Obesity: Involvement of Endogenous Adenosine via a2B Receptors 88
Microvascular Endothelial Dysfunction in Patients with Obesity 88
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 88
PACAP and gastrin regulate the histidine decarboxylase promoter via distinct mechanisms 87
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice 87
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 86
The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats 86
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 85
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 85
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-alpha 85
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 84
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 84
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 84
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 84
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 84
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine 84
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 83
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 83
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 83
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 82
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 82
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence 82
Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease 81
Sa1694 Colonic Inflammation in Experimental Parkinson's Disease: Evidence of Altered Colonic Tachykininergic Neurotransmissio 81
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage 80
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 80
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 80
Central GABA-A receptors exert a tonic inhibitory control on gastric pepsinogen secretion in anaesthetized rats 79
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats. 79
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds 79
Sa1702 Alterations of Colonic Neuromuscular Excitatory Tachykininergic Pathways in a Mouse Model of Diet Induced-Obesity 79
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 79
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 78
Adenosine and inflammation: what's new on the horizon? 76
W1720 Effects of Proton Pump Inhibitors on Healing of NSAID-Induced Gastric Ulcerations in the Presence of a Continued NSAID Treatment: Characterization of Molecular Mechanisms 76
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 76
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 76
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 73
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 73
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 73
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 72
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications 72
Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease 72
Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 down-regulation 72
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 71
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 71
Adenosine pathway and cancer: Where do we go from here? 71
Su1193 Rifaximin Prevents Enteric Bacteria Alterations and Inflammation in a Rat Model of Diclofenac-Induced Enteropathy 71
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 70
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase 70
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 70
Effects of L-DOPA/Benserazide Co-Treatment on Colonic Dysmotility and Enteric Inflammation Following Dopaminergic Nigrostriatal Neurodegeneration 69
Su2049 Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated With Bowel Inflammation in Rats 68
Microvascular endothelial dysfunction in human obesity: role of TNF-α 68
Role of cyclooxygenase-2 in the proliferative activity of gastrin on human colon cancer cells 67
Somatostatin modulates both cyclooxygenase-2 expression and proliferation in human colon cancer cells 67
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 65
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 65
Totale 8.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.772
article - articoli 44.642
book - libri 203
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 921
Totale 93.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.893 0 0 0 0 274 176 302 316 326 256 164 79
2020/20212.239 120 95 110 130 67 461 87 151 410 136 207 265
2021/20222.178 62 181 346 182 94 105 86 265 137 52 187 481
2022/20231.045 326 27 10 75 211 123 14 71 116 9 39 24
2023/2024760 33 62 63 64 68 48 47 47 25 75 105 123
2024/2025732 12 98 114 134 374 0 0 0 0 0 0 0
Totale 12.603